Using Brain Waves to Detect Pain
August 14, 2024
Chronic pain affects more than one-quarter of adults in the United States. This debilitating level of pain is difficult to treat for a number of
Category: Neuropharmacology
Home /
PF4 Offers Hope for Rejuvenating Aging Brains and Combatting Cognitive Decline
November 13, 2023
Three separate research studies point to a small protein, platelet-derived chemokine platelet factor 4 (PF4), as a possible tool for combating cognitive decline in aging
Donanemab Shows Promise in Slowing Cognitive Decline in Alzheimer’s Disease
July 10, 2023
In announcing positive results from a trial evaluating donanemab, Eli Lilly reported that the monoclonal antibody drug slowed cognitive decline among people with Alzheimer’s disease. The study
Could Deep Brain Stimulation Restore Memory After Brain Injury?
June 28, 2023
With a deep brain stimulation device called a “memory prosthesis,” researchers hope that they may one day be able to improve memory in people who
Research Examines the Mystery of End-of-Life Brain Activity
June 19, 2023
What happens in the brain on the verge of death? For hundreds of years, stories told by people who have come back from the brink
Research Reveals How Epidural Electrical Stimulation Helps People Walk Again
April 3, 2023
Building on previous research that showed how epidural electrical stimulation (EES) can help restore walking ability in people with spinal cord injuries, neuroscientists have now
The Gut-Brain Connection in Alzheimer’s Disease
March 27, 2023
Neurodegenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease, are often associated with the build-up of cellular debris, like misfolded proteins, within the brain.
Reporting Live From the Brain — Tiny Microscope Tracks Activity in Moving Mice
December 5, 2022
Human brains consist of around 86 billion neurons that connect and communicate with each other, forming an intricate network. Understanding how the human brain functions
Brain Implant Enables Communication in ALS Patient
June 29, 2022
As many as 30,000 people in the United States are currently diagnosed with amyotrophic lateral sclerosis, or ALS. This debilitating neurological condition is caused by
Immune Response Pathway a Possible Target to Treat Alzheimer’s Disease
June 6, 2022
Alzheimer’s disease (AD) is the most common form of dementia, affecting more than 50 million people globally. Projections show that, without a medical intervention, rates
Results May Disappoint, But Don’t Throw in the Tau on Treatments for Alzheimer’s Disease
April 25, 2022
Alzheimer’s disease (AD) is an irreversible degeneration of the brain and the most common form of dementia. Globally, more than 50 million people are living
Could Spider Webs Teach Us About Complex Brain Systems?
December 20, 2021
Scientists have spent decades working to understand how spiders spin their impossibly detailed, symmetrical webs. Despite those years of research, scientists remain baffled as to
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
NEWARK, Delaware, June 26, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new laboratory…
NEWARK, Delaware, June 10, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new clinical…
NEWARK, Delaware, May 21, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), continues to expand and align its…
Using Brain Waves to Detect Pain
August 14, 2024
Chronic pain affects more than one-quarter of adults in the United States. This debilitating level of pain is difficult to treat for a number of
PF4 Offers Hope for Rejuvenating Aging Brains and Combatting Cognitive Decline
November 13, 2023
Three separate research studies point to a small protein, platelet-derived chemokine platelet factor 4 (PF4), as a possible tool for combating cognitive decline in aging
Donanemab Shows Promise in Slowing Cognitive Decline in Alzheimer’s Disease
July 10, 2023
In announcing positive results from a trial evaluating donanemab, Eli Lilly reported that the monoclonal antibody drug slowed cognitive decline among people with Alzheimer’s disease. The study
Could Deep Brain Stimulation Restore Memory After Brain Injury?
June 28, 2023
With a deep brain stimulation device called a “memory prosthesis,” researchers hope that they may one day be able to improve memory in people who
Research Examines the Mystery of End-of-Life Brain Activity
June 19, 2023
What happens in the brain on the verge of death? For hundreds of years, stories told by people who have come back from the brink
Research Reveals How Epidural Electrical Stimulation Helps People Walk Again
April 3, 2023
Building on previous research that showed how epidural electrical stimulation (EES) can help restore walking ability in people with spinal cord injuries, neuroscientists have now
The Gut-Brain Connection in Alzheimer’s Disease
March 27, 2023
Neurodegenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease, are often associated with the build-up of cellular debris, like misfolded proteins, within the brain.
Reporting Live From the Brain — Tiny Microscope Tracks Activity in Moving Mice
December 5, 2022
Human brains consist of around 86 billion neurons that connect and communicate with each other, forming an intricate network. Understanding how the human brain functions
Brain Implant Enables Communication in ALS Patient
June 29, 2022
As many as 30,000 people in the United States are currently diagnosed with amyotrophic lateral sclerosis, or ALS. This debilitating neurological condition is caused by
Immune Response Pathway a Possible Target to Treat Alzheimer’s Disease
June 6, 2022
Alzheimer’s disease (AD) is the most common form of dementia, affecting more than 50 million people globally. Projections show that, without a medical intervention, rates
Results May Disappoint, But Don’t Throw in the Tau on Treatments for Alzheimer’s Disease
April 25, 2022
Alzheimer’s disease (AD) is an irreversible degeneration of the brain and the most common form of dementia. Globally, more than 50 million people are living
Could Spider Webs Teach Us About Complex Brain Systems?
December 20, 2021
Scientists have spent decades working to understand how spiders spin their impossibly detailed, symmetrical webs. Despite those years of research, scientists remain baffled as to
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
NEWARK, Delaware, June 26, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new laboratory…
NEWARK, Delaware, June 10, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new clinical…
NEWARK, Delaware, May 21, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), continues to expand and align its…
